Tendee LogoChatBlog
Public Tender Opportunity

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS]

Published on August 19, 2025

Tender Description

PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS] | Public Tender | tend.ee